| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SURG | Restricted Shares (Common Stock) | Award | $0 | +83.3K | +1.45% | $0.00 | 5.82M | Sep 1, 2024 | Direct | F1, F2 |
| transaction | SURG | Shares of Common Stock) | Sale | -$51.9K | -35.1K | -0.6% | $1.48 | 5.79M | Sep 3, 2024 | Direct | F3, F4 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | Consists of an RSA grant in the amount of 83,333 set to vest on November 1, 2024. |
| F2 | Includes (i) 83,334 RSAs that vested on July 1, 2024, (ii) 83,334 RSAs that are set to vested on August 1, 2024, (iii) RSAs vested on September 1, 2024, and (iv) RSAs vesting on October 1, 2024. |
| F3 | The purpose of the sale is solely to cover taxes with vesting of restricted share awards. |
| F4 | Based upon shares sold at a high price of $1.55, a low price of $1.43, and an average of $1.4782. The full breakdown of the prices for all shares sold will be provided at the request of the SEC. |